期刊文献+

早期乳腺癌保乳术后三维适形加速部分乳腺照射的疗效 被引量:7

Clinical effects of accelerated partial breast irradiation using three-dimensional conformalradiotherapy in patients with early breast cancer after breast-conserving therapy
原文传递
导出
摘要 目的分析早期低危乳腺癌保乳术后三维适形加速部分乳腺照射(APBI)的局部控制情况、美容评价及不良反应,并对剂量学结果进行质量评估。方法2008--2010年前瞻性临床Ⅱ期研究入组39例早期(0~I期)乳腺癌保乳术后患者,其中浸润性导管癌28例、导管原位癌5例、其他类型浸润性癌6例。放疗处方剂量为38.5Gy分10次,2次/d,问隔6h以上。不良反应评价采用NCI-CTC3.0标准,美容评价依据Harris美容级别标准。结果三维适形APBI技术应用于早期乳腺癌保乳术后获得了满意的剂量学结果,85%(33例)患者完全满足放疗质量控制评估标准。与ASTRO、GEC-ESTRO共识比较中危/高危患者比例分别为46%、18%和31%、3%。随访率100%,无一局部复发,无3、4级不良反应。放疗后6个月美容评价优异加良好者占90%(35例)。结论三维适形APBI人组患者选择恰当,局部控制、不良反应和美容评价初步结果较好。 Objective To assess the clinical effects of accelerated partial breast irradiation (APBI) using three-dimensional conformal radiotherapy (3DCRT) in patients with low-risk early breast cancer after breast-conserving therapy (BCT) with respect to dosimetric parameters, local control, toxicities, and cosmetic outcome. Methods Thirty-nine patients with early breast cancer ( stage 0--1 ) were enrolled in a prospective phase Ⅱ trial of APBI using 3DCRT in 2008--2010. Of all the patients, 28 had invasive ductal carcinoma, 5 had ductal carcinoma in situ, and 6 had other types of invasive carcinoma. The prescribed dose was 38.5 Gy/10 fractions twice daily, with an inter-fraction interval greater than 6 h. The toxicities were assessed according to the National Cancer Institute Common Toxicity Criteria, version 3. O. The cosmetic outcome was assessed according to the Harris breast cosmesis scale. Results The planning target volume coverage and normal-tissue dosimetry were appropriate in the APBI using 3DCRT. Dose homogeneity without deviation was achieved in 33 patients (85%). Of the total 39 patients, 46% met ASTRO' s “cautionary” criteria, and 18% met“unsuitable”criteria;also, 31% met GEC-ESTRO's“intermediate-risk”criteria, and 3% met“ high-risk” criteria. The follow-up rate was 100%. No patient experienced local recurrence, and no grade 3---4 toxicities were found. Cosmesis was good to excellent in 35 patients (90%) at 6 months after APBI. Conclusions The patients with early breast cancer after BCT are properly selected for APBI using 3DCRT, with satisfactory preliminary assessment results for local control, toxicities, and cosmetic outcome.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2013年第2期94-98,共5页 Chinese Journal of Radiation Oncology
基金 国家自然科学基金面上项目(81172504) 上海市科学技术委员会自然基金(10ZRl406700)
关键词 乳腺肿瘤 三维适形放射疗法 加速部分乳腺照射 乳腺肿瘤 外科学 乳房切 除术 区段 治疗结果 Breast neoplasms/three-dimensional radiotherapy Accelerated partial breast irradiation Breast neoplasms/surgery Mastectomy, segmental Treatment outcome
  • 相关文献

参考文献18

  • 1Kris MG, Benowitz SI, Adams S, et al. Clinical Cancer Advances 2010 :annual report on progress against cancer from the American society of clinical oncology. JCO ,2010,28:5327-5347.
  • 2Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med,1993,328 : 1557-1591.
  • 3Forrest AP, Stewart HJ, Everington D, et al. Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the scottish trial. Lancet, 1996,348:708-713.
  • 4Schnitt SJ, Hayman J, Gelman R, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer, 1996,77 : 1094-1100.
  • 5Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D- CRT). Int J Radiat Oncol Biol Phys,2003,55:302-311.
  • 6Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American society for radiation oncology ( ASTRO ). Int J Radiat Oncol Biol Phys, 2009,74:987-1001.
  • 7Polgar C, Van Limbergen E, Potter R, et al. Patient selection for accelerated partial breast irradiation (APBI) after breast conserving surgery: recommendations of the groupe Europeen de curietherapie-European society for therapeutic radiology and oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol,2010,94:264-273.
  • 8Trotti A, Colevas AD, Setser A, et ah CTCAE v3.0 :development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oneo1,2003,13 : 176-181.
  • 9Harris JR, Levene MB, Svensson G, et al. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys, 1979,5: 257-261.
  • 10Bartelink H, Horiot JC, Poortmans H, et al. hnpact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881 - 10882 trial. J Clin Oncol, 2007,25:3259-3265.

同被引文献84

  • 1黄国兴,周桂荣,李上芹,陈生,岳健,苏国森.横行腹直肌肌皮瓣应用于乳腺癌术后即时乳房再造的临床研究[J].中国肿瘤临床与康复,2020,0(3):319-322. 被引量:6
  • 2杨燕文,亓发芝.乳房重建中应用背阔肌肌皮瓣适应证及技术原则[J].中国实用外科杂志,2019,39(11):1161-1164. 被引量:11
  • 3Gianni L,Baselga J,Eiermann w,et a1.Feasibility and tolerability of sequential doxorubicin/paclitaxe1 followed by cyclophosphamide,methotrexate and fluofouraciland its effects on tumor response as preoperative therapy[J].Clin Cancer Res,2005,ll:8715-8721.
  • 4chen PY Wallace M, Milcell C, et al. Four-year efficacy, cosmesis,and toxicity using three-dimensional confonnal cetrnal beam radiation therapy to deliver accelerated partial breast irradiation[J]. Lnt J Radiat Oncol Phy,2010,76(4):991-997.
  • 5Huang E,Buchholz TA,Meric F,et al. Classifying local disease recurrences after breast conservation therapy based on location and histology:new primary tumors have more favorable outcomes than true local disease recurrences[J].cer,2002,95(10): 2059-2067.
  • 6Vicini F,Winter K,Wang J,et al.Initial efficacy results of RTOG 0319:three-dimensional conformal radiation therapy(3D- CRT)confined to the region of the lumpeetomy cavity for stage I/ II breast carcinoma [J]. Int J Radiat Onc01 Biol Phys,2010,77 (4) ~ 1120-1127.
  • 7Smith BD,Arthur DW,Buchholz TA,et al. Accelerated partial breast irradiation consensus statement from the american society for radiation oncology (ASTRO)[J]. J Radiat Oncol Bid Phys,2009,74(4) :987-1001.
  • 8Vicini F,Winter K,Straube W,et al. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of feasibility and reproducibility of radiation therapy oncology group (RTOG) study 0319 [J]. J Radiat Oncol Biol Phys,2005,63(5) : 1531-1537.
  • 9Trotti A, Colevas AD,Setser A,et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment[J]. Semin Radiat Onco1,2003,13(3): 176-181.
  • 10Ringash J,Whelan T,Elliott E,et al. Accuracy of ultrasound in localization of breast boost field [Jl. Radiother Oncol,2004,72 (1):61-66.

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部